Opinion / Bringing Patient Experience to Regulatory Decision-Making: Communication Pathway Needed
Takeda’s Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug…
AMERICAS
Pricing / Drugmakers Push Back Against Canada's New Regulations
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Mexican Healthcare Reforms / Question Marks Remain
The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July 2018 heralded a new era of hope and…
Indian Generics Companies in the US Snapshot
The US generics market stood at USD 69 billion in 2018 and is expected to grow to USD 86 billion by 2022. Made…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Coronavirus / Roche's New Test Gets FDA Emergency Use Authorization
Over the past few years, innovative Swiss giant Roche has combined its position as the world’s number 1 biotech…
Generics / Opportunities to Fix Medicare Part D
The Association for Accessible Medicines’ Chip Davis outlines the ways in which the US Medicare programme…
2020 Trends / A More Measured Tone at the J.P. Morgan Healthcare Conference
David Crean summarises the mood at the recent J.P. Morgan Healthcare Conference 2020 in San Francisco, noting a…
US FDA New Drug Approvals 2019 Snapshot
Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the…
In Conversation
Interview: Santiago Caviedes – Founder and Chief Economist, Humboldt Management, Ecuador
Santiago Caviedes, Harvard graduate, founder and chief economist of Humboldt Management, a company awarded multiple times for the precision of its forecasts in Ecuador by international institutions, gives a detailed overview of the country’s current economic situation and positive outlook for the future. Mr. Caviedes describes the country as a jewel to be discovered, which compares very well with its…
Latest Reports
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to…
Read more from Puerto Rico >>
Focus on Mexico
Hot Topics in Mexican Pharma
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the…
Mexican Healthcare Reforms: Question Marks Remain
The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July…
Read more from Mexico >>
Focus on Canada
Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has…
Alzheimer’s Disease Treatment: Canadian-Led Innovation…
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen's…
Read more from Canada >>
Focus on USA
How US Generics Firms are Responding to COVID-19 Supply…
AAM Interim President Jeff Francer outlines the vital role that biosimilar and…
First Antibiotic Discovered Using Artificial Intelligence
Artificial intelligence (AI) is increasingly being utilised in the drug…
Read more from USA >>
Focus on Colombia
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Read more from Colombia >>
Focus on Brazil
Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation…
Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil…
Read more from Brazil >>
The Big Chill: Temperature-Sensitive Pharma Logistics in Brazil
When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical…
Fighting Corruption in Mexican Pharma
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption,…
Puerto Rico / Community Pharmacies: Uniting Against the Big Chains
Going into a pharmacy has never been more convenient in the United States and its territories. People living near…
Coronavirus / How US Generics Firms are Responding to COVID-19 Supply Chain Risks
AAM Interim President Jeff Francer outlines the vital role that biosimilar and generics firms will play in filling…
Comprehensive Access to Medicines should be the Priority for National Pharmacare…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…
Coronavirus / Worldwide Demand for Protective Masks Booms Amid Infection Fears
The 2019 Wuhan coronavirus outbreak has seen a surge in demand for protective masks as publics across the world…